These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18317446)

  • 1. Use of GnRH agonists in GH-deficient patients: arguments for and against. The case for GnRH agonists in GH-deficient patients.
    Lee PA
    Pediatr Endocrinol Rev; 2008 Feb; 5 Suppl 2():744-9. PubMed ID: 18317446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of GnRH agonists in GH-deficient patients: arguments for and against. The case against GnRH agonists in GH-deficient patients.
    Rose SR
    Pediatr Endocrinol Rev; 2008 Feb; 5 Suppl 2():744, 750-4. PubMed ID: 18317447
    [No Abstract]   [Full Text] [Related]  

  • 3. A brief review of the addition of gonadotropin-releasing hormone agonists (GnRH-Ag) to growth hormone (GH) treatment of children with idiopathic growth hormone deficiency: Previously published studies from America.
    Reiter EO
    Mol Cell Endocrinol; 2006 Jul; 254-255():221-5. PubMed ID: 16787696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of puberty in growth hormone deficient children.
    Saggese G; Federico G; Barsanti S
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():329-34. PubMed ID: 10698597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of short stature with GnRH agonist and co-treatment with growth hormone: a controversial issue.
    Carel JC
    Mol Cell Endocrinol; 2006 Jul; 254-255():226-33. PubMed ID: 16787697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Final height after treatment of early puberty in short adopted girls with gonadotrophin releasing hormone agonist with or without growth hormone.
    Mul D; Oostdijk W; Waelkens JJ; Drop SL
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):185-90. PubMed ID: 16060912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [LH-RH agonist in subjects treated with growth hormone for somatotropin deficiency. Development of growth velocity and prediction of body height].
    Leheup B; Schaeffer L; Jeandel C; Pierson M
    Pediatrie; 1992; 47(4):291-5. PubMed ID: 1329014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement].
    Korpal-Szczyrska M; Dorant B; Kamińska H; Birkholz D; Niedźwiecki M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):31-4. PubMed ID: 16704859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone analog therapy for central precocious puberty and other childhood disorders affecting growth and puberty.
    Lee PA; Houk CP
    Treat Endocrinol; 2006; 5(5):287-96. PubMed ID: 17002488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precocious puberty and statural growth.
    Carel JC; Lahlou N; Roger M; Chaussain JL
    Hum Reprod Update; 2004; 10(2):135-47. PubMed ID: 15073143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for maximizing growth in puberty in children with short stature.
    Mauras N
    Endocrinol Metab Clin North Am; 2009 Sep; 38(3):613-24. PubMed ID: 19717007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A lifetime of growth hormone deficiency: a US pediatric perspective.
    Saenger P
    J Pediatr Endocrinol Metab; 2000; 13 Suppl 6():1337-42. PubMed ID: 11202206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult height in 24 patients treated for growth hormone deficiency and early puberty.
    Adan L; Souberbielle JC; Zucker JM; Pierre-Kahn A; Kalifa C; Brauner R
    J Clin Endocrinol Metab; 1997 Jan; 82(1):229-33. PubMed ID: 8989264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy with luteinizing hormone releasing hormone agonist (LHRHa) and growth hormone (GH) in central precocious puberty.
    Volta C; Regazzi C; Ndaka J; Vitale R; Bernasconi S
    Acta Biomed; 2005 Sep; 76(2):73-8. PubMed ID: 16350551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral density and body composition in Thai Precocious Puberty girls treated with GnRH agonist.
    Wacharasindhu S; Petwijit T; Aroonparkmongkol S; Srivuthana S; Kingpetch K
    J Med Assoc Thai; 2006 Aug; 89(8):1194-8. PubMed ID: 17048429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final height after combined growth hormone and GnRH analogue treatment in adopted girls with early puberty.
    Tuvemo T; Jonsson B; Gustafsson J; Albertsson-Wikland K; Aronson AS; Häger A; Ivarson S; Kriström B; Marcus C; Nilsson KO; Westgren U; Westphal O; Aman J; Proos LA
    Acta Paediatr; 2004 Nov; 93(11):1456-62. PubMed ID: 15513572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial growth deceleration during GnRH analogue therapy for precocious puberty.
    Mouat F; Hofman PL; Jefferies C; Gunn AJ; Cutfield WS
    Clin Endocrinol (Oxf); 2009 May; 70(5):751-6. PubMed ID: 19178517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can some growth hormone (GH)-deficient children benefit from combined therapy with gonadotropin-releasing hormone analogs and GH? Results of a retrospective study.
    Tauber M; Berro B; Delagnes V; Lounis N; Jouret B; Pienkowski C; Oliver I; Rochiccioli P
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1179-83. PubMed ID: 12629103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arachnoid cyst with GnRH-dependent sexual precocity and growth hormone deficiency.
    Huang HP; Tung YC; Tsai WY; Kuo MF; Peng SF
    Pediatr Neurol; 2004 Feb; 30(2):143-5. PubMed ID: 14984911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal use of growth hormone therapy for maximizing adult height in children born small for gestational age.
    Simon D; Léger J; Carel JC
    Best Pract Res Clin Endocrinol Metab; 2008 Jun; 22(3):525-37. PubMed ID: 18538291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.